Abstract
An antifungal protein with multiple stable biological activities unaffected by chemical modification of tyrosine and tryptophan, and a protein with N-terminal sequence and molecular mass resemblance to the antifungal protein but no identifiable activities were isolated from culture broth of Bacillus amyloliquefaciens. The findings are analogous to previous reports on thaumatin and thaumatin-like proteins.
Keywords: Antifungal protein, Bacillus amyloliquefaciens, HIV-1 reverse transcriptase, cancer cells, isolation
Protein & Peptide Letters
Title: Studies on an Antifungal Protein and a Chromatographically and Structurally Related Protein Isolated from the Culture Broth of Bacillus amyloliquefaciens
Volume: 16 Issue: 11
Author(s): Jack Ho Wong and Tzi Bun Ng
Affiliation:
Keywords: Antifungal protein, Bacillus amyloliquefaciens, HIV-1 reverse transcriptase, cancer cells, isolation
Abstract: An antifungal protein with multiple stable biological activities unaffected by chemical modification of tyrosine and tryptophan, and a protein with N-terminal sequence and molecular mass resemblance to the antifungal protein but no identifiable activities were isolated from culture broth of Bacillus amyloliquefaciens. The findings are analogous to previous reports on thaumatin and thaumatin-like proteins.
Export Options
About this article
Cite this article as:
Wong Ho Jack and Ng Bun Tzi, Studies on an Antifungal Protein and a Chromatographically and Structurally Related Protein Isolated from the Culture Broth of Bacillus amyloliquefaciens, Protein & Peptide Letters 2009; 16 (11) . https://dx.doi.org/10.2174/092986609789353718
DOI https://dx.doi.org/10.2174/092986609789353718 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gold - Old Drug with New Potentials
Current Medicinal Chemistry Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?
Current Cancer Drug Targets MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers MicroRNA-21 as a Novel Therapeutic Target
Current Cancer Therapy Reviews Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies
Current Vascular Pharmacology Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism Locked Nucleic Acid Holds Promise in the Treatment of Cancer
Current Pharmaceutical Design Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer
Current Gene Therapy Phytometabolites Targeting the Warburg Effect in Cancer Cells: A Mechanistic Review
Current Drug Targets Biological Basis of Novel Therapies for Myelodysplastic Syndrome
Current Cancer Therapy Reviews Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment
Current Medicinal Chemistry Patent Selections
Recent Patents on Biotechnology PARP Inhibitor Development for Systemic Cancer Targeting
Anti-Cancer Agents in Medicinal Chemistry Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design Transmembrane Phosphatases and Cancer Development, the Role of Protein Tyrosine Phosphatase-kappa (PTPκ) and Protein Tyrosine Phosphatase-mu (PTPμ)
Current Signal Transduction Therapy Aberrant Expression of MicroRNAs in B-cell Lymphomas
MicroRNA Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Cystathionine β-synthase Induces Multidrug Resistance and Metastasis in Hepatocellular Carcinoma
Current Molecular Medicine Drug-Induced Hypokalaemia
Current Drug Safety